Doron Therapeutics: Funding, Investors & Team (Oct 2026)
Doron Therapeutics is a clinical-stage biotechnology company that has developed intra-articular biologic drugs derived from placental tissue and consistently delivers a host of beneficial growth factors with potent anti-inflammatory, tissue-protective, and regenerative capabilities pivotal to the progressive and degenerative disease of osteoarthritis.
Doron Therapeutics has raised $11.0M across 1 funding round on record, the most recent a Series A of $11.0M announced in Nov 2024.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Doron Therapeutics Company Profile and Key Stats
Latest funding round on record: Nov 2024.
Doron Therapeutics Funding Rounds
Doron Therapeutics Founders and Leadership Team
Contact details for the Doron Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Doron Therapeutics Funding Compared to Other Biotechnology Startups
Doron Therapeutics' latest round of $11.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Doron Therapeutics in Biotechnology and Chapel Hill
Companies Similar to Doron Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Doron Therapeutics Funding FAQs
What does Doron Therapeutics do?
Doron Therapeutics is a clinical-stage biotechnology company that has developed intra-articular biologic drugs derived from placental tissue and consistently delivers a host of beneficial growth factors with potent anti-inflammatory, tissue-protective, and regenerative capabilities pivotal to the progressive and degenerative disease of osteoarthritis.
How much funding has Doron Therapeutics raised?
Doron Therapeutics has raised $11.0M across 1 round on record. The most recent is a Series A of $11.0M announced in Nov 2024.
When did Doron Therapeutics last raise funding?
Doron Therapeutics' most recent funding round on record is a Series A of $11.0M, announced in Nov 2024.
Who founded Doron Therapeutics?
FundedIQ lists Sarah Caley (Founder) at Doron Therapeutics.
Where is Doron Therapeutics headquartered?
Doron Therapeutics is based in Chapel Hill, North Carolina, United States.
How many employees does Doron Therapeutics have?
Doron Therapeutics is in the 1-10 employee band.
How does Doron Therapeutics' funding compare to other Biotechnology startups?
Doron Therapeutics' latest round of $11.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Doron Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Doron Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.